Groowe Groowe / Newsroom / SPRY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

SPRY News

ARS Pharmaceuticals, Inc. Common Stock

Lost Money on ARS Pharmaceuticals, Inc. (SPRY)? Urged to Join Class Action Before October 5, 2026 - Contact Levi & Korsinsky

accessnewswire.com
SPRY

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law

globenewswire.com
SPRY

SPRY Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in ARS Pharmaceuticals Securities Lawsuit - Contact SueWallSt

globenewswire.com
SPRY

Important Notice to Long-Term Shareholders of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY); Hub Group, Inc. (NASDAQ: HUBG); Insulet Corporation (NASDAQ: PODD); and Roblox Corporation (NYSE: RBLX): Grabar Law Office is Investigating Claims on Your Behalf

globenewswire.com
SPRY HUBG PODD RBLX

SPRY EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds ARS Pharmaceuticals Investors of Securities Class Action Lawsuit Deadline on October 5, 2026 Ready to Announce with Confidence?

newsfilecorp.com
SPRY

Levi & Korsinsky Notifies ARS Pharmaceuticals, Inc. (SPRY) Shareholders of Class Action Lawsuit and October 5, 2026 Deadline

accessnewswire.com
SPRY

ARS Pharmaceuticals, Inc. (SPRY) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 5, 2026

accessnewswire.com
SPRY

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit

prnewswire.com
SPRY

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPRY

accessnewswire.com
SPRY

Pomerantz LLP Calls Attention to Class Action Involving ARS Pharmaceuticals, Inc. – SPRY

accessnewswire.com
SPRY